|
Reverse acquisition (Detail Textuals) (Exchange Agreement (the "Reverse Acquisition"), DelMar Pharmaceuticals (BC) Ltd., USD $)
|
12 Months Ended | 1 Months Ended | |||
|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Jan. 25, 2013
Common stock
|
Jan. 25, 2013
Common stock
Stock Options
|
Jan. 25, 2013
United States Residents
Common stock
|
Jan. 25, 2013
Canadian Residents
Common stock
|
|
| Schedule Of Reverse Acquisition [Line Items] | |||||
| Number of shares issued and outstanding in exchange for transfer to Exchangeco | 13,070,000 | 4,340,417 | 8,729,583 | ||
| Number of common stock called by warrants | 3,360,000 | ||||
| Number of common stock purchased for options | 1,020,000 | ||||
| Percentage of outstanding shares of common stock | 80.10% | ||||
| Fair value of the shares issued | $ 1,690,004 | ||||
| Recapitalization loss on reverse acquisition | $ 3,731,684 | ||||